NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/08/2022
Voltar para busca
Dado oficial do USPTO
MOJUTO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
33
Atualização mais recente
09/08/2022
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
08/04/2019
Data de registro
09/08/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
09/08/2022
Última transação
09/08/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
25
Localização do titular
CH
Examinador
OH,WON TEAK
Unidade examinadora
M50
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Novartis AG
Representantes
Maury M. Tepper, III Tepper & Eyster, PLLC
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Publicações
Histórico de despachos e eventos da marca no USPTO.
33 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
09/08/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
24/05/2022
PUBO
PUBLISHED FOR OPPOSITION
24/05/2022
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
23/05/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/05/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/05/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/05/2022
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
14/08/2021
CREV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
09/08/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
14/07/2021
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
14/07/2021
CRTP
REG. CANCELLED - RESTORED TO PENDENCY
01/07/2021
APET
ASSIGNED TO PETITION STAFF
01/07/2021
RCII
REQUEST TO CANCEL INADVERTENTLY ISSUED REGISTRATION RECEIVED
15/06/2021
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
15/01/2021
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
11/01/2021
REIN
REINSTATED
11/05/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/05/2020
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
14/02/2020
DENC
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
01/11/2019
DETH
DEATH OF INTERNATIONAL REGISTRATION
01/11/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
22/10/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
13/08/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
13/08/2019
PUBO
PUBLISHED FOR OPPOSITION
06/08/2019
NPUB
NOTICE OF PUBLICATION
17/07/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/07/2019
MAFR
APPLICATION FILING RECEIPT MAILED
28/06/2019
DOCK
ASSIGNED TO EXAMINER
24/06/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
24/06/2019
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
14/06/2019
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
06/06/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MOJUTO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.